The medical nutrition market offers an extensive range of nutrition and dietary supplements that meet specific needs related to illness or trauma. With the growing prevalence of chronic diseases like diabetes, cancer, and digestive disorders, demand for medically tailored nutrition formulas to manage such conditions has increased significantly. Medical foods are developed to fulfill specific nutritional requirements for patients recovering from conditions like surgery, injury, or cancer that prevent them from eating normally and require unique macronutrient and micronutrient compositions. They are available in various forms like powders, liquids, capsules, soft gels, and bars for oral or tube feeding and help improve health outcomes.

The Global Medical Nutrition Market is estimated to be valued at US$ 13.91 Bn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period between 2024 to 2030

Key Takeaways

Key players operating in the medical nutrition market include Aprea Therapeutics, Novartis AG, Rocket Pharmaceuticals, Inc., GeneDx, BioMarin Pharmaceutical Inc., AbbVie Inc., Bristol Myers Squibb, Pfizer Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics, Editas Medicine, Fate Therapeutics, Inc., Regenxbio Inc., and uniQure N.V. These companies are focusing on developing innovative medical nutrition formulas and exploring new therapeutic areas.

The key opportunities in the Medical Nutrition Market Growth include rising incidences of chronic diseases, elderly population, increasing adoption of personalized nutrition, and expansion into developing regions. Asia Pacific is expected to witness high growth owing to improving healthcare infrastructure and rising healthcare spending in countries like China and India. North America currently dominates the market due to stringent regulations and advanced medical practices.

Rising global healthcare expenditure is anticipated to offer significant scope for the medical nutrition market players to offer customized nutrition support and gain a larger revenue share. Total healthcare spending worldwide is expected to reach USD 10 trillion by 2022 from USD 8.7 trillion in 2017 according to reports. This growing investment in healthcare from both public and private sources will augment demand.

Some of the key drivers which are propelling the growth of the Medical Nutrition Market Challenges And Opportunities include increasing prevalence of chronic diseases like diabetes, cancer, gastrointestinal disorders requiring clinical nutrition support. According to WHO, chronic diseases accounted for approximately 60% of all deaths worldwide in 2005 with rates steadily rising. The WHO also estimates cancer burden to increase by about 70% over the next two decades. Thus growing incidence of chronic conditions is anticipated to drive the need for specialized medical foods and supplements.

However, factors like lack of awareness, higher costs of customized nutrition products as compared to regular foods, and lack of reimbursements in some countries can restrain the market growth. Also, medical nutrition produced with novel ingredients require extensive clinical research and trials raising investment needs and risks which pose challenges. stringent regulations.

Segment Analysis
For the Medical Nutrition Market, the enteral nutrition segment currently dominates owing to its wide applications in pediatric and geriatric patients. In enteral nutrition, tube feeding formulas are given to patients who cannot consume sufficient amounts of food orally or via bottle due to illness or disability. As the global geriatric population is rising rapidly, the need for tube feeding solutions is also increasing significantly, thereby propelling growth of the enteral nutrition segment of the market.

The parenteral nutrition segment is also poised to witness strong growth over the forecast period on account of the availability of customized formulas and ease of administration through intravenous delivery. Parenteral nutrition is prescribed for patients who are unable to receive sufficient nutrients through oral or enteral routes.

Global Analysis
North America holds the leading share in the medical nutrition market due to advanced healthcare infrastructure and availability of branded products in the region. Additionally, the presence of major market players in countries like the US contributes to the large market size of North America. Europe is also among the lucrative regions for medical nutrition mainly because of increasing healthcare spending by governments in countries like Germany, UK, France etc. Meanwhile, Asia Pacific is anticipated to witness the highest CAGR during the forecast periodwith expanding medical tourism industry and rapidly growing aging population in China and Japan. African and Latin American regions also offer promising growth opportunities for players in the long run.

Get More Insights: Medical Nutrition Market

For More Insights Discover the Report In language that Resonates with you

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)